Search News

Corporate Industry Technology Medical Updates

BreathMo® ECMO

Corporate
magAssist was included in the catalogue of "Advantageous Enterprises in the Fourth Batch of Intellectual Property Strong Companies Cultivation Project in Suzhou City". 2024-12-20
Corporate
FDA Grants "Breakthrough Device" Designation to magAssist's NyokAssist® Interventional Ventricular Assist Device 2023-08-17

Tabs： membrane, heart transplant, cardiovascular patients, domestic ECMO products, intra-aortic balloon pump, advanced medical devices, Bridge-to-transplant, localization of high-end medical devices, p-VAD, surgically cannulated extracorporeal artificial hearts,